top of page

Recent Posts

Cisplatin Induces Hearing Loss in Most Pediatric Patients With High-Risk Neuroblastoma

Jun 5

1 min read

Following induction treatment for high-risk neuroblastoma, more than half of children experience cisplatin-induced hearing loss (CIHL), according to research published in JCO Clinical Advances.

Read more: https://www.cancertherapyadvisor.com/news/cisplatin-hearing-loss-pediatric-high-risk-neuroblastoma/

Childhood cancer: Why surviving the disease is only the beginning

CARE study reports complete regression of liver cancer in a child treated with novel immunotherapy

Pediatric cancer care coming closer to home for Niagara families

Childhood Chemotherapy Leaves Lasting DNA Damage in Healthy Tissues

Children with cancer are being saved, but are we breaking them in the process?

Surviving Is Not the End of the Story: Inside the Childhood Cancer Survivor Study

Trial provides first look at long-term outcomes of childhood immunotherapies

“Lower-Risk” Childhood Cancer May Be More Dangerous Than It Appears

Largest study supports three courses of radiation for children with deadly brain tumor

Unraveling how a deadly childhood cancer spreads could keep it in its place

Archive

Search By Tags

bottom of page